Magnesium Glycinate vs. Bisglycinate vs. Malate: Which Form Should You Take?

If you've typed "magnesium glycinate vs bisglycinate" into a search engine, you've already done more due diligence than most supplement buyers. The bad news: a lot of what you'll find is either wrong, vague, or exists to sell you something. The good news: the actual answer is simple once you cut through the naming mess.

Here it is upfront: magnesium glycinate and magnesium bisglycinate are the same compound. The confusion is a labelling artefact, not a chemical difference. Magnesium malate, on the other hand, is genuinely different — different structure, different mechanism, different use case.

This article breaks down the science on each form, gives you a clear decision table, and points to real products available across the EU, UK, Switzerland, and Norway — without the hype.

The Naming Confusion: Glycinate = Bisglycinate

Magnesium glycinate is the consumer-facing label name. Magnesium bisglycinate is the chemically accurate name. Both describe the exact same molecule: one magnesium ion chelated to two glycine molecules.

The "bis-" prefix simply means "two." Because a single glycine molecule cannot form a stable chelate with magnesium, commercially available products labelled "magnesium glycinate" almost universally contain the bisglycinate structure. Bolt Pharmacy's regulatory review of UK supplement labelling confirms this: products bearing either name are generally considered equivalent by clinicians and regulators.

The practical takeaway: if you see "glycinate" on a label, check the ingredient listing. If it reads magnesium bisglycinate or magnesium amino acid chelate, you have the same product regardless of the name on the front.

Magnesium Glycinate / Bisglycinate: Mechanism and What the Research Shows

How It's Absorbed

Standard magnesium salts (oxide, sulphate, carbonate) rely on ionic transport channels in the small intestine — channels that compete with calcium, zinc, and other divalent minerals. Magnesium bisglycinate bypasses this bottleneck. Because the magnesium is bound to glycine, it is recognised as a dipeptide and absorbed via the peptide transport pathway (PEPT1), which is a separate, high-capacity route.

According to Stefan Siebrecht's review of magnesium bisglycinate safety in human nutrition (2013), this chelated structure also protects the magnesium ion from binding with dietary phytates, tannins, and phosphates in the gut — compounds that would otherwise block absorption of inorganic forms. The result is superior bioavailability and substantially fewer gastrointestinal side effects compared to magnesium oxide or sulphate.

A 2020 cell-model study by Uberti et al., published in Nutrients (doi: 10.3390/nu12020573), demonstrated that magnesium bisglycinate chelate showed better intestinal permeability in Caco-2 human intestinal cells compared to sucrosomial magnesium.

Sleep: The Main Use Case

Magnesium's role in sleep runs through two overlapping mechanisms:

1. NMDA receptor antagonism. Magnesium ions block NMDA (N-methyl-D-aspartate) glutamate receptors in a voltage-dependent manner. This suppresses excessive neuronal excitation — the kind that keeps you awake and wired at midnight.
2. GABA potentiation. Magnesium ions interact with GABA-A receptors, enhancing the brain's primary inhibitory neurotransmitter system. A 2025 PMC review in Nature and Science of Sleep (PMC12535714) describes magnesium as exerting "a dual-pronged modulation of neural excitability" through simultaneous NMDA antagonism and GABA agonism.

The glycine component adds an independent sleep effect. Glycine acts as an inhibitory neurotransmitter and has been shown in controlled trials (Nakahara et al., Frontiers in Neurology, 2012; doi: 10.3389/fneur.2012.00061) to lower core body temperature — a physiological trigger for sleep onset.

Clinical evidence for sleep:

• Abbasi et al. (2012), Journal of Research in Medical Sciences, conducted an 8-week double-blind RCT in 46 elderly subjects supplementing with 500 mg elemental magnesium (as magnesium oxide). Results showed significant improvements in Insomnia Severity Index score (p = 0.006), sleep efficiency (p = 0.03), sleep onset latency (p = 0.02), and serum melatonin levels. (PMC3703169)
• Schuster et al. (2025), Nature and Science of Sleep, ran a randomised, double-blind, placebo-controlled trial in 155 adults with self-reported poor sleep (DRKS00031494). Participants received 250 mg elemental magnesium as bisglycinate or placebo nightly for 4 weeks. The bisglycinate group showed a significantly greater reduction in Insomnia Severity Index scores versus placebo (−3.9 vs. −2.3, p = 0.049), with exploratory data suggesting stronger effects in those with lower baseline dietary magnesium intake. Effect size was small (Cohen's d = 0.2), consistent with a modest but real benefit in a subclinical population.
• Mah & Pitre (2021), BMC Complementary Medicine and Therapies (doi: 10.1186/s12906-021-03297-z), pooled three RCTs in older adults and found that magnesium supplementation reduced sleep onset latency by 17.36 minutes versus placebo (p = 0.0006).
• Rawji et al. (2024), Cureus (doi: 10.7759/cureus.59317), systematically reviewed 15 studies and concluded that magnesium supplementation improved at least one sleep parameter in the majority of trials, with the strongest signal in individuals with low baseline magnesium status.

Bottom line on glycinate/bisglycinate: This is the form to reach for when your priority is sleep quality, nervous system calm, or you have a sensitive gut that doesn't tolerate oxide or citrate forms.

Magnesium Malate: Mechanism and What the Research Shows

What Makes It Different

Magnesium malate is magnesium bound to malic acid — an organic acid that plays a direct role in the Krebs cycle (also called the citric acid cycle), the metabolic pathway cells use to generate ATP. Malic acid is an intermediate between fumarate and oxaloacetate in this cycle, and it participates in the malate-aspartate shuttle, which transfers reducing equivalents across the inner mitochondrial membrane to maintain ATP production.

This is a fundamentally different mechanism from the neurological effects of glycinate. Where glycinate is about calming neural excitability and improving sleep architecture, malate is about cellular energy metabolism.

The Energy and Fatigue Research

The theoretical basis for magnesium malate in fatigue comes from research into conditions characterised by impaired mitochondrial energy production. Abraham & Flechas (1992), in the Journal of Nutritional Medicine (Vol. 3, No. 1, pp. 49–59), conducted an 8-week randomised, placebo-controlled, open-label crossover trial in 15 fibromyalgia patients. The group receiving magnesium (300–600 mg/day) and malate (1200–2400 mg/day) showed statistically significant improvement in Tender Point Index scores (p < 0.001) and myalgia symptoms. Importantly, subjective pain improvement was observed within 48 hours of starting supplementation with higher-dose malic acid, and deteriorated within 48 hours of stopping — suggesting the malate component was driving the rapid symptom response.

The proposed mechanism: in hypoxic or metabolically stressed muscle tissue, malic acid can accept reducing equivalents through a paired reaction (reduction to succinate, oxidation to oxaloacetate), effectively clearing the metabolic block that inhibits glycolysis. This allows ATP production to continue even when normal aerobic pathways are constrained.

Russell et al. (1995), Journal of Rheumatology (PMID: 8587088), tested a fixed low-dose preparation (Super Malic: 200 mg malic acid + 50 mg magnesium per tablet) in a double-blind crossover trial in 24 fibromyalgia patients. No significant effect was found at the fixed low dose, but open-label dose escalation (up to 6 tablets twice daily over 6 months) produced significant reductions in all three primary pain/tenderness measures. The authors concluded that higher doses and longer duration appear necessary for clinical effect.

A broader systematic review (Ferreira et al., Medwave, 2019) concluded that magnesium and malic acid supplementation "makes little or no difference on pain and on depressive symptoms" based on the available trial evidence — reflecting the overall limited size of the evidence base rather than definitive evidence of inefficacy.

For general users without fibromyalgia: the energy metabolism rationale holds in principle. Malic acid is a legitimate Krebs cycle intermediate, and magnesium is a required cofactor for ATP synthase. However, robust clinical trials specifically testing magnesium malate for general fatigue or energy in healthy adults do not currently exist in sufficient number to make confident efficacy claims. What can be said: the mechanistic rationale is sound, the safety profile is strong, and it remains a popular choice for morning dosing in people targeting energy and exercise recovery rather than sleep.

Bottom line on malate: Take it if your primary goal is energy support, exercise recovery, or daytime fatigue reduction. Do not take it before bed expecting sleep benefits — the energising effect of the malate component is the opposite of what you want at night.

Decision Table: Which Form, When, and How Much

EU/UK Brand Recommendations by Tier

These recommendations cover brands accessible to buyers in the EU, UK, Switzerland, and Norway. Prices are approximate and vary by retailer.

Budget (under £15 / €18)

Vitakruid Magnesium 150 Bisglycinate (Netherlands, EU-wide shipping)
Pure bisglycinate with added L-taurine (200 mg/tablet), 150 mg elemental magnesium per serving. No unnecessary fillers. Widely available in NL/BE/DE and ships across the EU. ~€15–18 for 90 tablets.

Prowise Advanced 4-in-1 Magnesium Complex (UK)
Blends glycinate, citrate, malate, and taurate in a single capsule. At roughly £0.17/day and stocked in Superdrug (£9.99), it punches above its price for users who want broad-spectrum coverage.

Holland & Barrett Magnesium Citrate (UK)
Not glycinate, but a solid bioavailable form at very low cost. Good entry-level option if bisglycinate products are out of budget.

Mid-tier (£15–30 / €18–35)

Viridian High Potency Magnesium (UK/EU)
300 mg per capsule from three forms (oxide, citrate, bisglycinate). Vegan, no fillers, sourced to strict ethical criteria. ~£20–25 for 60 capsules. Available via UK health retailers and across Europe.

Solgar Magnesium Glycinate (EU/UK)
Uses Albion-chelated bisglycinate. 120 mg elemental magnesium per capsule, 60-capsule packs ~£26. Well-established brand with good third-party testing track record. Available broadly in EU pharmacies and health stores.

Bonusan Magnesan Forte Plus (Netherlands/EU)
Bisglycinate combined with glycine and taurine as synergists. Popular in the Netherlands and Belgium, available through Dutch supplement retailers. ~€31–57 for 60–120 tablets.

Premium (£30+ / €35+)

Pure Encapsulations Magnesium Bisglycinate (EU/UK)
The professional-grade standard. Single-ingredient formula: magnesium bisglycinate, HPMC capsule, ascorbyl palmitate as antioxidant — nothing else. 240 mg elemental magnesium per 2-capsule serving. Available via Pharmamarket.eu (~€28–38), Naturitas UK, and VitalAbo across Europe. Frequently recommended by practitioners.

Thorne Magnesium Bisglycinate (Netherlands via Smeets & Graas, EU-wide)
Thorne's formulation comes in both capsule and powder form. ~€30–54 depending on format. NSF Certified for Sport — relevant for competitive athletes in Europe subject to anti-doping regulations.

PrizMAG Pure Magnesium Bisglycinate (Ireland/EU)
No fillers, no stearates, no unreacted magnesium oxide. Bestseller at Meaghers Pharmacy (Ireland) and available online. ~€25–35 for 90 capsules.

FAQ: Long-Tail Questions Answered Directly

Is magnesium glycinate the same as magnesium bisglycinate?

Yes. They are the same compound. "Bisglycinate" is the chemically accurate IUPAC-style name indicating that one magnesium ion is chelated to two glycine molecules. "Glycinate" is the simplified trade name most brands use on consumer packaging. When you see either label, you are buying the same thing in practical terms.

Which is better for sleep: magnesium glycinate or magnesium malate?

Glycinate/bisglycinate is the better choice for sleep. It works through NMDA receptor antagonism and GABA potentiation, reducing neuronal excitability and supporting melatonin regulation. The glycine component independently supports sleep onset by lowering core body temperature. Malate is energising due to its role in the Krebs cycle — taking it before bed can work against sleep for some people.

What is the best magnesium for sleep in the UK?

Magnesium bisglycinate is the form most consistently linked to sleep improvement in clinical trials (Abbasi et al., 2012; Schuster et al., 2025; Mah & Pitre, 2021). For UK buyers, accessible options include Viridian High Potency Magnesium, Solgar Magnesium Glycinate, and Pure Encapsulations Magnesium Bisglycinate. Take 200–400 mg elemental magnesium 30–60 minutes before bed.

Can I take magnesium glycinate and malate together?

Yes. They have different mechanisms and no known interaction. A practical split-dose approach: take malate in the morning with food for daytime energy support, and glycinate/bisglycinate in the evening for sleep and nervous system calm. Some multi-form products (like Prowise 4-in-1 or Viridian High Potency) combine both in a single capsule, which works well if you are not trying to time effects separately.

How much elemental magnesium is in magnesium bisglycinate?

Approximately 10–14% by weight. Magnesium bisglycinate has a molecular weight of roughly 172 g/mol, with magnesium accounting for about 14.2% of that. In practice, a capsule labelled "500 mg magnesium bisglycinate" contains approximately 70 mg of elemental magnesium. Always check the supplement facts panel for the elemental magnesium figure — this is the number that matters for dosing, not the weight of the chelate compound.

Does magnesium malate actually work for fatigue?

The mechanistic rationale is solid — malic acid is a genuine Krebs cycle intermediate and deficiency in ATP-dependent tissues has been documented in conditions like fibromyalgia. The clinical evidence is mixed: Abraham & Flechas (1992) and open-label data from Russell et al. (1995) show positive signals at higher doses; however, the total number of controlled trials remains small and the evidence base is not robust by modern standards. It is reasonable to trial magnesium malate for 4–8 weeks at adequate doses (300–400 mg elemental magnesium with 1200–2400 mg malic acid) if energy support is the goal, while recognising that the evidence does not yet meet the bar for a strong clinical recommendation.

Are these supplements safe to take daily long-term in Europe?

Magnesium bisglycinate and malate are classified as food supplements under EU Regulation (EC) No 1925/2006 and Directive 2002/46/EC. They are on the EU's approved list of mineral forms for use in supplements. Long-term daily supplementation at doses below the EFSA upper level (250 mg supplemental magnesium/day for adults) is considered safe for healthy individuals with normal kidney function. Higher doses have been used in clinical trials without serious adverse events, but kidney disease is a contraindication — the kidneys regulate magnesium excretion and impaired function can lead to accumulation.

Key Takeaways

• Magnesium glycinate and bisglycinate are the same compound. Do not let different labels confuse your purchasing decisions.
• Glycinate/bisglycinate is the evidence-supported form for sleep, with a dual mechanism via NMDA antagonism and GABA potentiation. Take it in the evening.
• Magnesium malate targets cellular energy metabolism through the Krebs cycle. Take it in the morning. The clinical evidence for fatigue is promising but limited.
• Aim for 200–400 mg elemental magnesium per day from supplements, not the weight of the chelate compound.
• For EU/UK buyers: Pure Encapsulations and Thorne are the go-to premium options; Vitakruid and Viridian are strong mid-range choices; Prowise delivers solid value at the budget end.